|
KMID : 1172020170180020001
|
|
Journal of Korean Bioethics Association
2017 Volume.18 No. 2 p.1 ~ p.20
|
|
|
An Ethical Response Model for Genome Editing Technology - Focusing on Dynamic and Plural Risk Model -
|
|
Mok Kwang-Su
|
|
|
Abstract
|
|
|
|
The purpose of this paper is to suggest a model for responding to ethical issues of genome editing technology. I argue three things. First, I argue that genome editing technology should be differently understood in two senses, its narrow sense and wide sense. The former is a technical sense but the latter is a clinical sense. Through this distinction, we should understand that current researches of genome editing technology are not related to a clinical but only a technical advance. Second, I argue that preclinical researches including animal experimentation should be sufficiently performed and, then, clinical trials about human embryo or human to develop a new treatment can do. Through this claim, we should remember that current requests of clinical trial with human embryo are too hasty and impatient. Third, I argue that dynamic and plural risk model can effectively respond to ethical issues or risks of genome editing technology. This is because this model can dynamically respond to risks according to the advance of knowledge concerning genome editing technology.
|
|
|
KEYWORD
|
|
|
genome editing technology, risk, uncertainty, dynamic and plural risk model, preclinical research and clinical trial, programmable nuclease (or gene scissors)
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|